BML Capital Management’s HilleVax HLVX Stock Holding History

BML Capital Management’s Portfolio HLVX Stock Details HLVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-91,913	Closed	-$183K	–	23
2025 Q2	$183K	Buy	91,913 +71,153	+343%	+$130K	0.14%	23
2025 Q1	$30.1K	Hold	20,760	–	–	0.02%	26
2024 Q4	$43K	Buy	20,760 +1,000	+5%	+$1.88K	0.03%	25
2024 Q3	$34.8K	Buy	+19,760	New	+$50.7K	0.02%	29

BML Capital Management's HLVX Position: Q3 2025 in Review

BML Capital Management sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 91,913 shares — an estimated $183K sold.

BML Capital Management first reported a position in HLVX in Q3 2024 and held it in 4 quarters. The position peaked at $183K in Q2 2025. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

BML Capital Management reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
BML Capital Management sold 91,913 HilleVax shares in Q3 2025, an estimated $183K.
BML Capital Management first reported a position in HilleVax in Q3 2024 and held it in 4 quarters.
BML Capital Management's HilleVax position peaked at $183K in Q2 2025.
1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on BML Capital Management's 13F filing for Q3 2025, filed 10 Nov 2025.